Get notified when PRPH files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Going Concern (worsened) — Going-concern language remains in both filings with no material change in financial substance.
  • Restatement (new) — The current filing adds a new Note 16 disclosing a material restatement of previously issued Q1 2026 financial statements due to errors in revenue, cost of goods sold, and deferred revenue.
  • Delisting (removed) — The entire Nasdaq delisting risk factor present in the baseline filing has been removed from the current filing.
OTC: PRPH ProPhase Labs, Inc. 10-Q/A

revenue $1.2M, net income -$5.2M. ProPhase Labs restates Q1 2026 results: revenue up, net loss narrows, but going concern doubt persists

Filed July 9, 2026 · Period ending March 31, 2026 · Compared to 10-Q/A Jul 7, 2026 · ~1 min read

Key Financials

SEC XBRL

Period financials are unchanged from the original 10-Q/A (same period end Mar 31, 2026). This amendment updates disclosure only — see the diff below.

Key Changes

  • high

    Subsequent event: On June 4, 2026, the Company’s wholly-owned subsidiary, DNA Complete, Inc. (“DNA Complete”), entered into an agreement of sale of future receipts (the “Third 2026 Future Receipts Financing Agreement”) with Legendary F…

    Notes: Subsequent Events verify on EDGAR →
  • high

    Restated Q1 2026 net revenue is $1.2 million, up from the previously reported $0.5 million, while cost of revenues rises to $0.9 million.

    MD&A: Net revenue verify on EDGAR →
  • high

    Net loss from continuing operations narrows to $5.2 million, or $(0.42) per share, from $5.4 million, or $(0.43) per share.

    MD&A: Net loss verify on EDGAR →

3 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (CRWD 10-Q) is open in full — no account needed.

Partner

Trade PRPH commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 30, 2026 · How we verify